New JTH Research on Bleeding Risk in Pregnant Women Treated for Acute Venous Thromboembolism
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn:
“The risk of bleeding in pregnant women with acute venous thromboembolism treated with anticoagulants: an international multidatabase cohort study
This multinational study assessed bleeding risk in pregnant women treated with low-molecular-weight heparins (LMWH) for acute VTE. It found no significant difference in bleeding risk between LMWH types or dosing schedules, highlighting the need for further research to optimize anticoagulation care in pregnancy.”
Title: The risk of bleeding in pregnant women with acute venous thromboembolism treated with anticoagulants: an international multidatabase cohort study
Authors: Camille Simard, Isabelle Malhamé, Christopher Filliter, Annika Vivirito, Kristian B. Filion, Haim Abenhaim, Dirk Enders, Antonios Douros, Vicky Tagalakis
Read the full article here.
Find similar posts on Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda